Nederland - Nederlands - CBG-MEB (College ter Beoordeling van Geneesmiddelen)

teva b.v. swensweg 5 2031 ga haarlem - methylfenidaathydrochloride 10 mg/stuk - tablet - calcium hydrogen phosphate (hydrate form unknown) (e 341) (ri) ; cellulose, microkristallijn (e 460) ; lactose 1-water ; magnesiumstearaat (e 470b) ; maÏszetmeel, gepregelatineerd - methylphenidate

Nederland - Nederlands - CBG-MEB (College ter Beoordeling van Geneesmiddelen)

teva b.v. - methylfenidaathydrochloride; - tablet - methylphenidate

Nederland - Nederlands - CBG-MEB (College ter Beoordeling van Geneesmiddelen)

fresenius kabi nederland b.v. amersfoortseweg 10 e 3712 bc huis ter heide - lidocainehydrochloride 1-water 10 mg/ml - oplossing voor infusie - natriumchloride ; water, gezuiverd, - lidocaine

Nederland - Nederlands - CBG-MEB (College ter Beoordeling van Geneesmiddelen)

fresenius kabi nederland b.v. amersfoortseweg 10 e 3712 bc huis ter heide - lidocainehydrochloride 1-water 20 mg/ml - oplossing voor infusie - natriumchloride ; water, gezuiverd, - lidocaine

Nederland - Nederlands - CBG-MEB (College ter Beoordeling van Geneesmiddelen)

samenwerkende apothekers nederland b.v. kralingseweg 201 3062 ce rotterdam - broomhexinehydrochloride samenstelling overeenkomend met ; broomhexine - drank - bananensmaakstof ; benzoËzuur (e 210) ; ethanol ; hydroxyethylcellulose ; levomenthol (l- vorm) ; saccharoide natrium x-water (e 954) ; sorbitol (d-)(e 420) ; water, gezuiverd ; wijnsteenzuur, (l (+) vorm) (e 334), - bromhexine

Nederland - Nederlands - CBG-MEB (College ter Beoordeling van Geneesmiddelen)

samenwerkende apothekers nederland b.v. - xylometazolinehydrochloride samenstelling overeenkomend met; xylometazoline; - neusspray, oplossing - xylometazoline

Nederland - Nederlands - CBG-MEB (College ter Beoordeling van Geneesmiddelen)

samenwerkende apothekers nederland b.v. kralingseweg 201 3062 ce rotterdam - xylometazolinehydrochloride samenstelling overeenkomend met ; xylometazoline - neusspray, oplossing - benzalkoniumchloride ; dinatriumedetaat 2-water ; dinatriumwaterstoffosfaat 12-water (e 339) ; natriumchloride ; natriumdiwaterstoffosfaat 2-water (e 339) ; water, gezuiverd, - xylometazoline

Nederland - Nederlands - CBG-MEB (College ter Beoordeling van Geneesmiddelen)

samenwerkende apothekers nederland b.v. kralingseweg 201 3062 ce rotterdam - xylometazolinehydrochloride samenstelling overeenkomend met ; xylometazoline - neusspray, oplossing - citroenzuur 1-water (e 330) ; glycerol 85 per cent (e 422) ; trinatriumcitraat 2-water (e 331) ; water voor injectie - xylometazoline

Europese Unie - Nederlands - EMA (European Medicines Agency)

mylan ireland limited - sitagliptin hydrochloride monohydrate, metformin hydrochloride - diabetes mellitus, type 2 - geneesmiddelen die worden gebruikt bij diabetes - for adult patients with type 2 diabetes mellitus:sitagliptin/metformin hydrochloride mylan is indicated as an adjunct to diet and exercise to improve glycaemic control in patients inadequately controlled on their maximal tolerated dose of metformin alone or those already being treated with the combination of sitagliptin and metformin. sitagliptin/metformin hydrochloride mylan is indicated in combination with a sulphonylurea (i. , drievoudige combinatietherapie) als aanvulling op dieet en lichaamsbeweging bij patiënten die onvoldoende gecontroleerd op hun maximale getolereerde dosis van metformine en een enz.). sitagliptin/metformin hydrochloride mylan is indicated as triple combination therapy with a peroxisome proliferator-activated receptor gamma (pparg) agonist (i. , a thiazolidinedione) as an adjunct to diet and exercise in patients inadequately controlled on their maximal tolerated dose of metformin and a pparg agonist. sitagliptin/metformin hydrochloride mylan is also indicated as add-on to insulin (i. , triple combination therapy) as an adjunct to diet and exercise to improve glycaemic control in patients when stable dose of insulin and metformin alone do not provide adequate glycaemic control.

Europese Unie - Nederlands - EMA (European Medicines Agency)

sun pharmaceutical industries europe b.v. - sitagliptin fumarate, metformin hydrochloride - diabetes mellitus, type 2 - geneesmiddelen die worden gebruikt bij diabetes - for adult patients with type 2 diabetes mellitus:sitagliptin/metformin hydrochloride sun is indicated as an adjunct to diet and exercise to improve glycaemic control in patients inadequately controlled on their maximal tolerated dose of metformin alone or those already being treated with the combination of sitagliptin and metformin. sitagliptin/metformin hydrochloride sun is indicated in combination with a sulphonylurea (i. , drievoudige combinatietherapie) als aanvulling op dieet en lichaamsbeweging bij patiënten die onvoldoende gecontroleerd op hun maximale getolereerde dosis van metformine en een enz.). sitagliptin/metformin hydrochloride sun is indicated as triple combination therapy with a peroxisome proliferator-activated receptor gamma (pparγ) agonist (i. , a thiazolidinedione) as an adjunct to diet and exercise in patients inadequately controlled on their maximal tolerated dose of metformin and a pparγ agonist. sitagliptin/metformin hydrochloride sun is also indicated as add-on to insulin (i. , triple combination therapy) as an adjunct to diet and exercise to improve glycaemic control in patients when stable dose of insulin and metformin alone do not provide adequate glycaemic control.